Valentina Prevolnik Rupel: No One Should Be Left Behind

Valentina Prevolnik Rupel

Thomas L. Harrison Joins the Board of Directors of P53 Inc.

Thomas L. Harrison

The Asher Series Survivorship and Beyond Presented by OncoDaily LA

The Asher Series Survivorship and Beyond Presented by OncoDaily LA

Hesham ElGhazaly: Honored and Excited to be Announced as a Member of the ABC Global Alliance Board of Directors

Hesham ElGhazaly

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

Zacharoula Sidiropoulou: What Really Works in Breast Cancer Screening Across Europe?

Zacharoula Sidiropoulou

COSA-IPOS 2025 Kicks Off with Over 1,200 Attendees

COSA-IPOS 2025

Prince William Opens Up About Talking to His Children About Kate Middleton’s Cancer

Prince William Opens Up About Talking to His Children About Kate Middleton’s Cancer

OncoCalendar

Loading Events

« All Events

  • This event has passed.

Immunotherapy and GI cancer. Learnings from the ESMO Congress 2024, ESMO Immuno-Oncology Congress 2024 and Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024 by SPCC

Dec 17, 2024 • 6:00 PM - 7:00 PM
SPCC

Immunotherapy and GI cancer. Learnings from the ESMO Congress 2024, ESMO Immuno-Oncology Congress 2024 and Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024 by SPCC will be held at December 17th, 2024.

Join this Live Webinar on advancements in gastrointestinal (GI) cancer care, featuring experts Van Cutsem Eric, Neuzillet Cindy, and Ruiz-Garcia Erika. The event will explore recent breakthroughs in minimally invasive surgery, targeted therapies, and immunotherapy, which are improving survival rates. The speakers will discuss how molecular insights are driving personalized treatment and transforming patient outcomes. Don’t miss this opportunity to learn about the latest developments and future directions in GI cancer care.

The webinar will begin with an introduction by Eric Van Cutsem (BE), setting the stage for the discussions on the latest advancements in immuno-oncology for gastrointestinal cancers. Cindy Neuzillet (FR) will then present on the progress of immuno-oncology in biliary and pancreatic cancers, highlighting the most recent breakthroughs and clinical developments in these challenging and often difficult-to-treat cancers. Following this, Erika Ruiz Garcia (MX) will focus on the advances in immuno-oncology for colorectal and stomach cancer, exploring how emerging therapies are improving outcomes for patients with these common malignancies.

After the presentations, there will be an open discussion and Q&A session, where attendees can engage directly with the speakers, ask questions, and share insights. The webinar will conclude with closing remarks from Eric Van Cutsem (BE), summarizing the key points discussed and providing a forward-looking perspective on the future of immuno-oncology in GI cancer care. This session promises to be an informative and interactive opportunity for healthcare professionals and researchers to learn about the latest advancements in this rapidly evolving field.

Link to register and access the session.

 

Details

Organizer